Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88768494 | 8876849 | 4 | F | 201201 | 20120716 | 20120426 | 20130107 | PER | PHEH2012US003712 | NOVARTIS | 42.00 | YR | M | N | 112.20000 | KG | 20121205 | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88768494 | 8876849 | 1 | PS | GILENYA | 1 | ORAL | 22527 | 0.5 | MG | CAPSULE | QD | ||||||||
| 88768494 | 8876849 | 3 | C | DEPAKOTE (VALPROATE SEMISODIUM) | 1 | 0 | |||||||||||||
| 88768494 | 8876849 | 5 | C | CAPTOPRIL (CAPTOPRIL) (CAPTOPRIL) | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88768494 | 8876849 | 1 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88768494 | 8876849 | Abdominal pain upper | |
| 88768494 | 8876849 | Diarrhoea | |
| 88768494 | 8876849 | Flatulence | |
| 88768494 | 8876849 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 88768494 | 8876849 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88768494 | 8876849 | 1 | 20120124 | 20120515 | 0 |